Boston was buzzing this summer – and not just with tourists and Red Sox fans. From June 16–19, over 30,000 attendees and 5,000+ companies converged for BIO International Convention 2025, the world’s largest biotech gathering.
CarboHyde was proudly represented, and we were on a clear mission:
To scout novel cyclodextrin-based technologies and explore emerging applications across pharma, biotech, and beyond.
And the hunt delivered!
While a full Cyclodextrin Tales edition is coming soon, here are a few spoilers from the cutting edge of CD science:
- Antibody–drug conjugates enhanced by cyclodextrin-based linkers
- Microneedle drug delivery systems using CDs for improved stability and release
- Vaccine platforms incorporating CDs as solubility enhancers and immune boosters
- And surprisingly, cyclodextrins as active ingredients themselves in metabolic and neurodegenerative conditions
This year’s BIO wasn’t just about science—it was about scale and energy. In 3.5 days, we connected with dozens of innovators, start-ups, CDMO reps, and academic pioneers.
